This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2025 before the market opens ...

Its longitudinal design, coupled with clinician-reported data from routine practice, will generate a comprehensive understanding of Alzheimer's therapy outcomes in real-world settings. The registry ...

Learn more about whether Charles River Laboratories International, Inc. or Thermo Fisher Scientific Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key ...

A conserved signaling axis linking Drosophila adipose tissue to nephrocyte function reveals how obesity can drive kidney dysfunction and points to new opportunities for therapeutic intervention.

Invitrogen Corp History - Read about Invitrogen Corp, History of Invitrogen Corp on The Economic Times ...